GlaxoSmithKline Plc

GlaxoSmithKline Plc

GlaxoSmithKline Plc

Overview
Date Founded

1999

Headquarters

980 Great West Road, Brentford, Middlesex, TW8 9GS, GBR

Type of Company

Public

Employees (Worldwide)

99.4K

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Wholesale: Consumer Non-Durables/Sundries
Medical Products & Equipment
Biotechnology

Company Description

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Website
Contact Data
Trying to get in touch with decision makers at GlaxoSmithKline Plc? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial Officer

Senior Vice President & General Counsel

Chief Digital & Technology Officer

Chief Scientific Officer & President of Research & Development

Chief Medical Officer

Chief Digital Officer

Chief Strategy Officer

Chief Executive Officer, GSK Consumer Healthcare

President, Global Pharmaceuticals

Board of Directors

Head-Corporate Finance & Strategy at Mesoblast Ltd.

President & Chief Executive Officer at Dana-Farber Cancer Institute, Inc.

Chief Financial Officer at GlaxoSmithKline Plc

Former Executive Vice President & Chief Financial Officer at Merck & Co., Inc.

Chairman at Human Genome Sciences, Inc.

Vice Chairman-Governing Board at Swiss Bankers Association

Chief Executive Officer at GlaxoSmithKline Plc

Former Executive Vice President & Chief Financial Officer at Bristol-Myers Squibb Company

Trustee & Vice President at The Energy Institute (United Kingdom)

Partner at Clayton Dubilier & Rice LLC

Paths to GlaxoSmithKline Plc
Potential Connections via
Relationship Science
You
GlaxoSmithKline Plc
Owners & Shareholders
Details Hidden

Dodge & Cox employs in-house fundamental bottom-up research, a rigorous valuation discipline, and maintains a long-term investment horizon. Their investment decisions are made by a team of seasoned investment professionals. The firm's approach stresses an evaluation of risk relative to opportunity and they seek investments that they believe are undervalued by the market.

Details Hidden

BIM-UK utilizes their market insights, global reach, proprietary technology, culture of information sharing and focus on risk management to deliver performance in all market environments. For their equity investments, the firm utilizes style-neutral (core and high performance), value and growth processes. They have combined a top-down and bottom-up approach for their fixed-income and balanced products. The fixed-income investment team specializes in particular market segments and focuses on quantitative analysis. Their Pinpoint system enables them to identify and track fixed-income issuers and credits. Investment teams are autonomous. Process implementation is formalized through investment committees and is reviewed monthly with the CIO, the head of performance and risk management and team leaders.

Details Hidden

SIM utilizes a contrarian investment approach supported by fundamental, in-house research, regular company visits and their group's global network. Research is shared worldwide within the parent group and is organized in specialist teams, with local specialists contributing their expertise to global sector teams. The firm also utilizes their proprietary software, the Global Research Investment Database, to integrate and distribute in-house and external research, assisting investment managers in portfolio construction. They manage risk through another proprietary tool called Portfolio Risk Investment Strategy Manager (PRISM). SIM employs fundamental and quantitative approaches to manage aggregate, government, credit and high yield portfolios.

Recent Transactions
Details Hidden

Unilever PLC, Hindustan Unilever Ltd. purchase GlaxoSmithKline Consumer Healthcare India from GlaxoSmithKline Plc

Details Hidden

Bora Pharmaceuticals Co., Ltd. purchases Glaxosmithkline, Inc. /Mississauga Facility from GlaxoSmithKline Plc

Details Hidden

Aziende Chimiche Riunite Angelini Francesco - A.C,R.A.F. - SpA, Finaf SpA purchase Glaxosmithkline Plc /ThermaCare Topical Pain Mgt Bus from GlaxoSmithKline Plc

Transaction Advisors
Legal Advisor

Advised onGlaxoSmithKline Plc purchases TESARO, Inc.

Legal Advisor

Advised onGlaxoSmithKline Plc purchases Stiefel Laboratories, Inc. from Blackstone Corporate Private Equity, Blackstone (Legacy S Corp.), Inc.

Accountant

Advised onGlaxoSmithKline Plc purchases Block Drug Co., Inc.

Legal Advisor

Advised onGlaxoSmithKline Plc purchases GlaxoSmithKline Pharmaceuticals Ltd.

Legal Advisor

Advised onGlaxoSmithKline Plc purchases UCB SA/ Emerging Markets Ops from UCB S. A.

Legal Advisor

Advised onGlaxoSmithKline Plc purchases UCB SA/ Emerging Markets Ops from UCB S. A.

Advisors & Consultants
Consultant

The Energy Project energizes people and transforms companies, offering a detailed blueprint for fueling a fully engaged workforce. Drawing on the multidisciplinary science of high performance, we do this at three levels: We train people to perform sustainably at the highest levels by more skillfully managing their energy across four dimensions: physical, emotional, mental and spiritual to develop actionable strategies that help them to become more energized, focused and productive. We teach leaders to become Chief Energy Officers, who mobilize, inspire, focus, direct and regularly recharge the energy of those they lead. We partner with companies to help them better meet the core needs of their employees, so they’re freed, fueled and inspired to bring the best of themselves to work every day. Demand is exceeding our capacity. Time is the resource we’ve traditionally relied on to get more done. The problem with time is that it’s finite, and most of us no longer have additional hours left to invest at work. Energy, by contrast, can be expanded and regularly renewed. Drawing on the multidisciplinary science of high performance, The Energy Project has developed a set of simple principles and highly actionable practices for more effectively managing energy to drive higher levels of engagement, productivity, and innovation. Our clients range from companies such as Google, Coca Cola, Target, Sony, Ernst & Young, and Pfizer to organizations such as the Los Angeles Police Department, the Cleveland Clinic, Kipp Schools and many others.

Advisor

Partner at Nixon Peabody LLP

Legal Advisor

Partner at King & Spalding LLP

Legal Advisor

Partner at Debevoise & Plimpton LLP

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Taisho Pharmaceutical Holdings Co. Ltd. engages in the management and administration of its group companies that manufactures and sells over-the-counter (OTC) drugs, foods, and other goods, etc. It operates through the following segments: Self-Medication and Prescription Pharmaceutical. The Self-Medication segment conducts research and development (R&D), manufacturing and sale of over-the-counter drugs, quasi-drugs, food, and general medical and hygiene supplies. The Prescription Pharmaceutical segment handles R&D, manufacturing, and sale of ethical drugs. It also provides the manufacture and sale of prescription pharmaceuticals; and businesses incidental or related thereto. The company was founded on October 3, 2011 and is headquartered in Tokyo, Japan.

Key Stats and Financials As of 2019
Market Capitalization
$83.3B
Total Enterprise Value
$122B
Earnings Per Share
$0.94
Revenue
$33.8B
Net Profit
$4.64B
EBITDA
$10.1B
EBITDAMargin
29.97%
Total Debt
$30.5B
Total Equity
$18.4B
Three Year Compounded Annual Growth Rate Of Revenue
6.57%
Five Year Compounded Annual Growth Rate Of Revenue
7.97%
Enterprise Value Sales
3.61x
Enterprise Value EBITDAOperating
12.05x
TEVNet Income
26.25x
Debt TEV
0.25x
Investments
Details Hidden

Enigma Diagnostics Ltd. develops next generation rapid molecular diagnostic instrument platforms for decentralized and point-of-care settings. It offers Enigma Instruments, Enigma MiniLab, and Enigma technology and IP. The firm has operation in Salisbury and San Diego. The company was founded in 2004 and is headquartered in Salisbury, the United Kingdom.

Details Hidden

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in applying a precision medicine approach to acquiring, developing and commercializing medicines. It focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer. Its pipeline include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.

Details Hidden

Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom.

Investors
Details Hidden

Executive Director at Jardine Matheson Holdings Ltd.

Details Hidden

Hereditary Peer at United Kingdom House of Lords

Details Hidden

Life Peer at United Kingdom House of Lords

Suppliers
AptarGroup, Inc. Personal Products | Crystal Lake, IL

AptarGroup, Inc. develops manufactures and sales of consumer product dispensing systems. It operates through the following business segments: Beauty & Home, Pharma and Food & Beverage. The Beauty & Home segment primarily sells pumps, aerosol valves and accessories to the personal care and household markets and pumps and decorative components to the fragrance/cosmetic market. The Pharma segment supplies pumps and metered dose inhaler valves to the pharmaceutical market worldwide. The Food & Beverage segment sell dispensing and non-dispensing closures and, to a lesser degree, spray pumps and aerosol valves to the food and beverage markets. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

Liberty Property Trust Real Estate Investment Trusts | Malvern, PA

Liberty Property Trust (NYSE:LRY) is a $6.9 billion real estate investment trust which owns 77.8 million square feet of office and industrial space in more than 21 markets throughout the United States and the United Kingdom (as of Sep. 30, 2012). Founded in 1972 and headquartered outside of Philadelphia, Liberty develops, acquires, leases and manages properties with the mission to enhance people's lives through extraordinary work environments. As an extension of this promise, Liberty is one of the nation's leading developers of high-performance green buildings. Liberty's more than 700 office and industrial properties offer exceptional locations, flexible design, thoughtful amenities, cost efficient operations and state-of-the-art technology to the company's 2,300 tenants. Liberty continuously increases the value of its portfolio through expert management, marketing and development

Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Procter & Gamble Co. Personal Products - Cincinnati, Ohio

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment comprises of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home Care segment consist of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Perrigo Co. Plc Pharmaceuticals - Dublin, Ireland

Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Self-Care International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by GlaxoSmithKline Plc. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of GlaxoSmithKline Plc's profile does not indicate a business or promotional relationship of any kind between RelSci and GlaxoSmithKline Plc.